-Reuters
Why Is Humana Stock Trading Higher Today?
Humana Inc (NYSE: HUM) reported Q2 adjusted EPS of $8.94 from $8.76 a year ago,
Related Posts
RBC Capital Maintains Outperform on Evolent Health, Raises Price Target to $44
RBC Capital analyst Sean Dodge maintains Evolent Health (NYSE:EVH) with a Outperform and raises the price target from $40 to $44.
Taiwan Semi Rides AI Wave, Reports $7.1B Revenue In May
World's largest contract chipmaker, TSMC, saw 30% sales increase in May due to high demand for AI and recovering consumer electronics. Nvidia and Google drive AI unicorn growth.
Intra-Cellular Therapies Announces CAPLYTA Data Presentations At The American Society Of Clinical Psychopharmacology Annual Meeting
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced several CAPLYTA